Black Diamond Therapeutics Ownership | Who Owns Black Diamond Therapeutics?
Black Diamond Therapeutics Ownership Summary
Black Diamond Therapeutics is owned by 67.98% institutional investors, 0.63% insiders, and 31.39% retail investors. T. rowe price investment management is the largest institutional shareholder, holding 18.51% of BDTX shares. BB Biotech AG Ord is the top mutual fund, with 15.05% of its assets in Black Diamond Therapeutics shares.
BDTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Black Diamond Therapeutics | 67.98% | 0.63% | 31.39% |
| Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
| Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| T. rowe price investment management | 10.51M | 18.51% | $26.07M |
| Vestal point capital, lp | 5.60M | 9.86% | $13.89M |
| Nea management company | 4.45M | 7.83% | $11.03M |
| Blackrock | 3.22M | 6.21% | $14.99M |
| Bellevue group | 2.73M | 4.81% | $6.78M |
| Vanguard group | 2.41M | 4.27% | $5.17M |
| Tang capital management | 2.07M | 3.64% | $5.13M |
| Artal group | 1.05M | 2.02% | $4.88M |
| Blackrock funding, inc. /de | 1.09M | 1.92% | $2.71M |
| Siren | 1.05M | 1.84% | $2.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nea management company | 4.45M | 0.83% | $11.03M |
| Vestal point capital, lp | 5.60M | 0.73% | $13.89M |
| Dafna capital management | 471.00K | 0.32% | $1.17M |
| Tang capital management | 2.07M | 0.26% | $5.13M |
| Bellevue group | 2.73M | 0.15% | $6.78M |
| Awm investment company | 500.00K | 0.14% | $1.24M |
| Siren | 1.05M | 0.13% | $2.60M |
| Artal group | 1.05M | 0.12% | $4.88M |
| Boxer capital | 506.00K | 0.12% | $2.36M |
| Brown wealth management | 100.00K | 0.08% | $248.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.22M | 0.00% | 1.84M |
| Marshall wace, llp | 737.88K | 0.00% | 737.88K |
| Renaissance | 904.00K | 0.00% | 650.20K |
| Dimensional fund advisors lp | 661.44K | 0.00% | 405.58K |
| Millennium management | 558.08K | 0.00% | 331.33K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -3.53M |
| Blackrock funding, inc. /de | 1.09M | 0.00% | -2.38M |
| Laurion capital management lp | - | - | -878.29K |
| Exoduspoint capital management, lp | - | - | -872.68K |
| Ally bridge group (ny) | - | - | -835.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Marshall wace, llp | 737.88K | 0.00% | 737.88K | $1.83M |
| Arrowstreet capital, limited partnership | 138.14K | 0.00% | 138.14K | $342.60K |
| Graham capital management | 72.02K | 0.00% | 72.02K | $178.61K |
| Susquehanna portfolio strategies | 57.14K | 0.00% | 57.14K | $141.72K |
| Ieq capital | 35.55K | 0.00% | 35.55K | $88.15K |
Sold Out
| Holder | Change |
|---|---|
| Geowealth management | -26.00 |
| Northwestern mutual wealth management | -35.00 |
| Lindbrook capital | -83.00 |
| Tsfg | -100.00 |
| Farther finance advisors | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 92 | 4.55% | 38,616,348 | -5.24% | 67 | 1.31% | 63 | 90.91% | 17 | -43.33% |
| Mar 31, 2025 | 88 | -1.12% | 40,752,553 | -14.93% | 71 | 1.00% | 32 | -39.62% | 31 | 82.35% |
| Dec 31, 2024 | 89 | -21.93% | 47,905,427 | -1.67% | 84 | 1.14% | 53 | -20.90% | 17 | -19.05% |
| Sep 30, 2024 | 113 | 21.51% | 48,573,437 | 4.44% | 85 | 1.07% | 67 | 19.64% | 20 | 11.11% |
| Jun 30, 2024 | 93 | 4.49% | 46,507,345 | 18.77% | 89 | 1.13% | 56 | 12.00% | 18 | -18.18% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 8.52M | 15.05% | - |
| T. Rowe Price Small-Cap Stock | 2.50M | 4.40% | 131.58K |
| T. Rowe Price US Small-Cap Core Equity | 2.50M | 4.40% | 130.07K |
| T. Rowe Price Small-Cap Value | 2.42M | 4.25% | -2.83K |
| Vanguard US Total Market Shares ETF | 1.33M | 2.35% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.30M | 2.29% | -28.70K |
| T. Rowe Price Instl Small-Cap Stock | 1.28M | 2.26% | 48.61K |
| T. Rowe Price U.S. SC Core Eq Tr-D | 1.26M | 2.22% | 46.68K |
| T. Rowe Price U.S. SC Value Eq Tr-D | 1.25M | 2.20% | 6.86K |
| T. Rowe Price U.S. SC Value Eq Tr-Z | 1.24M | 2.19% | 2.28K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 19, 2025 | BIOTECH GROWTH N V | - | Sell | $4.00M |
| Mar 19, 2025 | BIOTECH GROWTH N V | - | Sell | $2.31M |
| Mar 19, 2025 | BIOTECH GROWTH N V | - | Sell | $582.90K |
| Mar 19, 2025 | BIOTECH GROWTH N V | - | Sell | $2.07M |
| Mar 19, 2025 | BIOTECH GROWTH N V | - | Sell | $837.16K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 7 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | - |
BDTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools